A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
| Autor: | Sundström, Johan, Kristófi, Robin, Östlund, Ollie, Bennet, Louise, Eliasson, Björn, Jansson, Stefan, Leksell, Janeth, Almby, Kristina, Lundqvist, Martin, Eriksson, Jan W. |
|---|---|
| Zdroj: | In Journal of Diabetes and Its Complications October 2021 35(10) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect